Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 122 for covid

Edit search filters
  1. Tele-Medicine in an Advanced Prostate Cancer Clinic

    Rochester, MN

  2. Development of a Peptide-Based SARS-CoV-2 Candidate Vaccine

    Rochester, MN

  3. Voice Signal PASC Study

    Rochester, MN

  4. Neuro Databank/Biobank of COVID-19

    Rochester, MN

  5. Immunogenetics of COVID-19 Immune Response

    Rochester, MN

  6. Effects of Long-COVID on Breathing During Exercise

    Rochester, MN

  7. Uncovering Mechanisms Post COVID-19 Chronic Lung Sequelae

    Rochester, MN

  8. A Retrospective Study of Long COVID Symptoms and Associated Factors

    Eau Claire, WI

  9. Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

    Jacksonville, FL

  10. Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and Associated Precursors

    Rochester, MN

.

Mayo Clinic Footer